Regen BioPharma, Inc.
RGBP
$0.058
-$0.0034-5.54%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.80K | 100.00 | 700.00 | 61.80K | 78.10K |
| Total Receivables | 149.70K | 122.30K | 94.90K | 67.10K | 39.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 300.00 | 51.30K | 64.30K | 23.40K | 5.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 0.00 |
| Total Current Assets | 151.70K | 173.70K | 159.90K | 152.40K | 123.00K |
|
|
|||||
| Total Current Assets | 151.70K | 173.70K | 159.90K | 152.40K | 123.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 169.50K | 191.40K | 177.60K | 170.20K | 140.80K |
|
|
|||||
| Total Accounts Payable | 33.70K | 36.00K | 29.70K | 29.40K | 29.80K |
| Total Accrued Expenses | 1.75M | 1.71M | 1.66M | 1.66M | 1.64M |
| Short-term Debt | 210.40K | 107.50K | 294.80K | 219.20K | 50.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 757.30K | 744.60K | 499.90K | 499.90K | 499.90K |
| Total Finance Division Other Current Liabilities | 3.11M | 3.27M | 2.88M | 2.92M | 2.95M |
| Total Other Current Liabilities | 3.11M | 3.27M | 2.88M | 2.92M | 2.95M |
| Total Current Liabilities | 5.87M | 5.87M | 5.37M | 5.33M | 5.17M |
|
|
|||||
| Total Current Liabilities | 5.87M | 5.87M | 5.37M | 5.33M | 5.17M |
| Long-Term Debt | -- | -- | -- | -- | 143.70K |
| Short-term Debt | 210.40K | 107.50K | 294.80K | 219.20K | 50.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00 | -- | -- | -- | 0.00 |
| Total Liabilities | 5.87M | 5.87M | 5.37M | 5.33M | 5.32M |
|
|
|||||
| Common Stock & APIC | 15.46M | 15.46M | 15.42M | 15.19M | 15.05M |
| Retained Earnings | -20.95M | -20.93M | -20.62M | -20.35M | -20.22M |
| Treasury Stock & Other | -204.80K | -204.80K | -- | -- | 0.00 |
| Total Common Equity | -5.70M | -5.68M | -5.20M | -5.16M | -5.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | -5.70M | -5.68M | -5.20M | -5.16M | -5.18M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.70M | -5.68M | -5.19M | -5.16M | -5.18M |
|
|
|||||